Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS)

Q: What does CUSIP 00461U105 represent in this 13F holders report?

CUSIP 00461U105 is the security identifier for ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share in Q1 2021?

95 institutional investors reported ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 00461U105

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, $0.00001 par value per share
Shares outstanding: 121,058,810
Total 13F shares: 45,417,666
Share change: +13,508,576
Total reported value: $1,298,594,000
Put/Call ratio: 64%
Price per share: $25.20
Number of holders: 95
Value change: +$509,363,836
Number of buys: 64
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 00461U105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.7%	3,268,178	$21,145,000	—	31 Dec 2020	13F
Rock Springs Capital Management LP	13F	Company	2.2%	2,676,100	$17,314,000	—	31 Dec 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.9%	2,250,000	$14,558,000	—	31 Dec 2020	13F
VR Adviser, LLC	13F	Company	1.6%	1,954,932	$12,648,000	—	31 Dec 2020	13F
Sofinnova Investments, Inc.	13F	Company	1.6%	1,911,573	$12,368,000	—	31 Dec 2020	13F
Parkman Healthcare Partners LLC	13F	Company	1.5%	1,875,336	$12,133,000	—	31 Dec 2020	13F
Vivo Capital, LLC	13F	Company	1.4%	1,647,214	$10,657,000	—	31 Dec 2020	13F
Foresite Capital Management III, LLC	13F	Company	1.3%	1,620,244	$10,483,000	—	31 Dec 2020	13F
EcoR1 Capital, LLC	13F	Company	1.2%	1,509,812	$9,768,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	1.2%	1,487,141	$9,621,000	—	31 Dec 2020	13F
Samsara BioCapital, LLC	13F	Company	1.1%	1,362,612	$8,816,000	—	31 Dec 2020	13F
Commodore Capital LP	13F	Company	1.1%	1,336,275	$8,646,000	—	31 Dec 2020	13F
Endurant Capital Management LP	13F	Company	0.93%	1,126,675	$7,290,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	0.8%	973,170	$6,297,000	—	31 Dec 2020	13F
Foresite Capital Management IV, LLC	13F	Company	0.79%	951,384	$6,155,000	—	31 Dec 2020	13F
Ghost Tree Capital, LLC	13F	Company	0.54%	650,000	$4,206,000	—	31 Dec 2020	13F
Aisling Capital Management LP	13F	Company	0.52%	634,455	$4,105,000	—	31 Dec 2020	13F
Stenham Asset Management Ltd	13F	Company	0.42%	510,000	$3,300,000	—	31 Dec 2020	13F
Octagon Capital Advisors LP	13F	Company	0.29%	350,000	$2,265,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.27%	324,957	$2,102,000	—	31 Dec 2020	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.25%	306,900	$1,985,000	—	31 Dec 2020	13F
Ikarian Capital, LLC	13F	Company	0.25%	300,000	$1,941,000	—	31 Dec 2020	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.2%	239,400	$1,549,000	—	31 Dec 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0.18%	222,648	$1,441,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.17%	208,926	$1,352,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	0.17%	205,984	$1,333,000	—	31 Dec 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.12%	150,000	$971,000	—	31 Dec 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0.12%	139,229	$880,000	—	31 Dec 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	110,549	$715,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.09%	104,619	$677,000	—	31 Dec 2020	13F
Verition Fund Management LLC	13F	Company	0.08%	98,845	$640,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.08%	93,472	$605,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.07%	90,687	$586,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.07%	86,092	$557,000	—	31 Dec 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.07%	85,362	$551,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.06%	78,040	$505,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.05%	65,628	$425,000	—	31 Dec 2020	13F
CAPSTONE INVESTMENT ADVISORS, LLC	13F	Company	0.05%	61,534	$398,000	—	31 Dec 2020	13F
HighTower Advisors, LLC	13F	Company	0.05%	57,500	$373,000	—	31 Dec 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.04%	51,461	$333,000	—	31 Dec 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.04%	50,000	$324,000	—	31 Dec 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.04%	47,633	$308,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.04%	47,200	$305,000	—	31 Dec 2020	13F
Telemetry Investments, L.L.C.	13F	Company	0.04%	46,800	$303,000	—	31 Dec 2020	13F
683 Capital Management, LLC	13F	Company	0.04%	46,168	$299,000	—	31 Dec 2020	13F
J. Goldman & Co LP	13F	Company	0.04%	45,076	$292,000	—	31 Dec 2020	13F
Cambridge Investment Research Advisors, Inc.	13F	Company	0.04%	44,773	$290,000	—	31 Dec 2020	13F
CITIGROUP INC	13F	Company	0.04%	42,475	$275,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	41,342	$267,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	32,936	$213,000	—	31 Dec 2020	13F

Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) as of Q1 2021

As of 31 Mar 2021, Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,417,666 shares. The largest 10 holders included VR Adviser, LLC, Rock Springs Capital Management LP, Foresite Capital Management IV, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Cormorant Asset Management, LP, Foresite Capital Management III, LLC, Parkman Healthcare Partners LLC, and Vivo Capital, LLC. This page lists 95 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.